Literature DB >> 12458684

Augmented expression of the tight junction protein occludin in brain endothelial cell line TR-BBB by rat angiopoietin-1 expressed in baculovirus-infected Sf plus insect cells.

Himashi Iizasa1, Sun-Hye Bae, Tomoko Asashima, Tomohide Kitano, Noriko Matsunaga, Tetsuya Terasaki, Young-Sook Kang, Emi Nakashima.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12458684     DOI： 10.1023/a:1020921818105

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  15 in total

1.  mRna expression and transport characterization of conditionally immortalized rat brain capillary endothelial cell lines; a new in vitro BBB model for drug targeting.

Authors:  K I Hosoya; T Takashima; K Tetsuka; T Nagura; S Ohtsuki; H Takanaga; M Ueda; N Yanai; M Obinata; T Terasaki
Journal:  J Drug Target       Date:  2000       Impact factor: 5.121

2.  Angiopoietin-1 protects the adult vasculature against plasma leakage.

Authors:  G Thurston; J S Rudge; E Ioffe; H Zhou; L Ross; S D Croll; N Glazer; J Holash; D M McDonald; G D Yancopoulos
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

3.  Prolactin, alone or in combination with glucocorticoids, enhances tight junction formation and expression of the tight junction protein occludin in mammary cells.

Authors:  K Stelwagen; H A McFadden; J Demmer
Journal:  Mol Cell Endocrinol       Date:  1999-10-25       Impact factor: 4.102

4.  Angiopoietin-1 is an apoptosis survival factor for endothelial cells.

Authors:  H J Kwak; J N So; S J Lee; I Kim; G Y Koh
Journal:  FEBS Lett       Date:  1999-04-09       Impact factor: 4.124

5.  Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning.

Authors:  S Davis; T H Aldrich; P F Jones; A Acheson; D L Compton; V Jain; T E Ryan; J Bruno; C Radziejewski; P C Maisonpierre; G D Yancopoulos
Journal:  Cell       Date:  1996-12-27       Impact factor: 41.582

6.  Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions.

Authors:  J R Gamble; J Drew; L Trezise; A Underwood; M Parsons; L Kasminkas; J Rudge; G Yancopoulos; M A Vadas
Journal:  Circ Res       Date:  2000-09-29       Impact factor: 17.367

7.  Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression.

Authors:  J D Huber; K A Witt; S Hom; R D Egleton; K S Mark; T P Davis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-03       Impact factor: 4.733

8.  Angiopoietin-1 and -2 coiled coil domains mediate distinct homo-oligomerization patterns, but fibrinogen-like domains mediate ligand activity.

Authors:  W N Procopio; P I Pelavin; W M Lee; N M Yeilding
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

9.  Possible involvement of phosphorylation of occludin in tight junction formation.

Authors:  A Sakakibara; M Furuse; M Saitou; Y Ando-Akatsuka; S Tsukita
Journal:  J Cell Biol       Date:  1997-06-16       Impact factor: 10.539

10.  Expression of processed envelope protein of hepatitis C virus in mammalian and insect cells.

Authors:  Y Matsuura; S Harada; R Suzuki; Y Watanabe; Y Inoue; I Saito; T Miyamura
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103
View more
  1 in total

1.  Localization of angiopoietin-1 and Tie2 immunoreactivity in rodent ependyma and adjacent blood vessels suggests functional relationships.

Authors:  Brooke N Horton; Rajanikant B Solanki; Kiran F Rajneesh; Piotr Kulesza; Agnieszka A Ardelt
Journal:  J Histochem Cytochem       Date:  2009-09-28       Impact factor: 2.479
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.